178 related articles for article (PubMed ID: 28431915)
21. In-vitro pharmacokinetic/pharmacodynamic model data suggest a potential role of new formulations of posaconazole against Candida krusei but not Candida glabrata infections.
Beredaki MI; Arendrup MC; Mouton JW; Meletiadis J
Int J Antimicrob Agents; 2021 Mar; 57(3):106291. PubMed ID: 33508404
[TBL] [Abstract][Full Text] [Related]
22. [Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin].
Diaz MC; Camponovo R; Araya I; Cerda A; Santander MP; Carrillo-Muñoz AJ
Rev Esp Quimioter; 2016 Jun; 29(3):151-4. PubMed ID: 27167765
[TBL] [Abstract][Full Text] [Related]
23. Synergistic effect of thymoquinone and nystatin in the treatment of oral candidiasis; an in vitro study.
Özdal Zincir Ö; Özdal U; Ünlü Ö; Demirci M; Katiboğlu AB; Egil E; Altan Şallı G
Odontology; 2022 Apr; 110(2):330-337. PubMed ID: 34657217
[TBL] [Abstract][Full Text] [Related]
24. Correlation between broth microdilution and disk diffusion methods for antifungal susceptibility testing of caspofungin, voriconazole, amphotericin B, itraconazole and fluconazole against Candida glabrata.
Kiraz N; Dag I; Oz Y; Yamac M; Kiremitci A; Kasifoglu N
J Microbiol Methods; 2010 Aug; 82(2):136-40. PubMed ID: 20493911
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the Antifungal Effect of Chicory Extracts on Candida Glabrata and Candida Krusei in a Laboratory Environment.
Eslami H; Babaei H; Falsafi P; Rahbar M; Najar-Karimi F; Pourzare-Mehrbani S
J Contemp Dent Pract; 2017 Nov; 18(11):1014-1020. PubMed ID: 29109313
[TBL] [Abstract][Full Text] [Related]
26. [In vitro nystatin sensitivity of vaginal isolates of Candida spp].
Andreu CM; Medina YE; Gonzáles TC; Llanes DM
Rev Cubana Med Trop; 2001; 53(3):194-8. PubMed ID: 15846923
[TBL] [Abstract][Full Text] [Related]
27. Candida glabrata among Candida spp. from environmental health practitioners of a Brazilian Hospital.
Savastano C; de Oliveira Silva E; Gonçalves LL; Nery JM; Silva NC; Dias AL
Braz J Microbiol; 2016; 47(2):367-72. PubMed ID: 26991302
[TBL] [Abstract][Full Text] [Related]
28. In vitro Synergistic Activity of Caspofungin Plus Polymyxin B Against Fluconazole-Resistant Candida glabrata.
Adams EK; Ashcraft DS; Pankey GA
Am J Med Sci; 2016 Mar; 351(3):265-70. PubMed ID: 26992255
[TBL] [Abstract][Full Text] [Related]
29. [Fungi isolated from the vagina and their susceptibility to antifungals].
Macura AB; Skóra M
Ginekol Pol; 2012 Jun; 83(6):433-8. PubMed ID: 22880463
[TBL] [Abstract][Full Text] [Related]
30. Voriconazole efficacy against Candida glabrata and Candida krusei: preclinical data using a validated in vitro pharmacokinetic/pharmacodynamic model.
Beredaki MI; Georgiou PC; Siopi M; Kanioura L; Arendrup MC; Mouton JW; Meletiadis J
J Antimicrob Chemother; 2020 Jan; 75(1):140-148. PubMed ID: 31665417
[TBL] [Abstract][Full Text] [Related]
31. [Prerequisites for effective therapy of chronic recurrent vaginal candidiasis].
Kunzelmann V; Tietz HJ; Rossner D; Czaika V; Hopp M; Schmalreck A; Sterry W
Mycoses; 1996; 39 Suppl 1():65-72. PubMed ID: 8767274
[TBL] [Abstract][Full Text] [Related]
32. Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents.
Chen TC; Chen YH; Chen YC; Lu PL
Kaohsiung J Med Sci; 2012 Jun; 28(6):306-15. PubMed ID: 22632885
[TBL] [Abstract][Full Text] [Related]
33. Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing of 10 systemically active antifungal agents when tested against Candida spp.
Pfaller MA; Castanheira M; Messer SA; Rhomberg PR; Jones RN
Diagn Microbiol Infect Dis; 2014 Jun; 79(2):198-204. PubMed ID: 24736096
[TBL] [Abstract][Full Text] [Related]
34. Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods.
Montagna MT; Lovero G; Coretti C; Martinelli D; De Giglio O; Iatta R; Balbino S; Rosato A; Caggiano G
BMC Microbiol; 2015 May; 15():106. PubMed ID: 25990252
[TBL] [Abstract][Full Text] [Related]
35. Synergistic anticandidal activity of xanthorrhizol in combination with ketoconazole or amphotericin B.
Rukayadi Y; Lee K; Lee MS; Yong D; Hwang JK
FEMS Yeast Res; 2009 Dec; 9(8):1302-11. PubMed ID: 19663917
[TBL] [Abstract][Full Text] [Related]
36. Metabolite profiling, antifungal, biofilm formation prevention and disruption of mature biofilm activities of Erythrina senegalensis stem bark extract against Candida albicans and Candida glabrata.
Harley BK; Quagraine AM; Neglo D; Aggrey MO; Orman E; Mireku-Gyimah NA; Amengor CD; Jato J; Saaka Y; Fleischer TC
PLoS One; 2022; 17(11):e0278096. PubMed ID: 36441750
[TBL] [Abstract][Full Text] [Related]
37. Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel.
Samra Z; Yardeni M; Peled N; Bishara J
Eur J Clin Microbiol Infect Dis; 2005 Sep; 24(9):592-5. PubMed ID: 16172856
[TBL] [Abstract][Full Text] [Related]
38. The in vitro post-antifungal effect of nystatin on Candida species of oral origin.
Ellepola AN; Samaranayake LP
J Oral Pathol Med; 1999 Mar; 28(3):112-6. PubMed ID: 10069538
[TBL] [Abstract][Full Text] [Related]
39. Species Distribution and In Vitro Antifungal Susceptibility of Vulvovaginal Candida Isolates in China.
Wang FJ; Zhang D; Liu ZH; Wu WX; Bai HH; Dong HY
Chin Med J (Engl); 2016 May; 129(10):1161-5. PubMed ID: 27174323
[TBL] [Abstract][Full Text] [Related]
40. [In vitro susceptibility of vaginal isolates of Candida vs clotrimazole and nystatin].
Suárez VL; Fernández Andreu CM
Rev Cubana Med Trop; 2003; 55(3):138-45. PubMed ID: 15849917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
